V. D. di Maio

Clinical Profile of RSV Breakthrough Infections After Nirsevimab Introduction

The introduction of universal prophylaxis with nirsevimab for all children in their first epidemic season has substantially reduced the burden of respiratory syncytial virus (RSV). However, a small number of breakthrough infections continue to occur despite immunization, mostly in previously healthy infants, and these...